At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 21 enrolled
Drug / intervention
Acai Juice Productdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Study Acai Juice Product in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising Prostate Specific Antigen (PSA)
In Brief
A Phase 2 clinical trial evaluating Acai Juice Product for Prostate Cancer. Completed, enrolled 21 participants across 1 site.
Detailed Summary
Men who have Prostate Specific Antigen (PSA) recurrence with low PSA levels and long doubling times do not require immediate treatment with androgen deprivation therapy and may be safely observed. In these situations where current treatment options may cause more unnecessary side effects than anticipated benefit, it is reasonable to use a low-risk natural product such as Acai Juice Product with antioxidant properties to evaluate whether there are any anti-cancer effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedJan 2012
Primary CompletionDec 2013
Study CompletionFeb 2018
TodayJul 2026
First PostedJan 31, 2012
Enrollment StartNov 4, 2011
Primary CompletionDec 25, 2013
Study CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.4 years ago
Interventions
Acai Juice Productdrug
2 ounces of Acai Juice Product twice daily.